Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Mantra Bio
company
About
Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $9M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Mantra Bio develops a novel next-generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). The Company's REVEAL platform, which integrates computational and wet biology, and automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics is reproducibly made at high purity.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$34M
Mantra Bio has raised a total of
$34M
in funding over 2 rounds. Their latest funding was raised on
Jan 4, 2023 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 4, 2023 | Series A | $9M | 1 | — | — | Detail |
| Jul 29, 2020 | Series A | $25M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Mantra Bio is funded by 1 investors.
Allen & Company
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Allen & Company
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
